Bordeaux Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Sell |
802
-7
| -0.9% | -$3.68K | 0.05% | 100 |
|
|
2025
Q1 | $513K | Sell |
809
-8
| -1% | -$5.07K | 0.1% | 87 |
|
|
2024
Q4 | $582K | Buy |
817
+8
| +1% | +$5.7K | 0.09% | 80 |
|
|
2024
Q3 | $850K | Buy |
809
+52
| +7% | +$54.7K | 0.15% | 64 |
|
|
2024
Q2 | $796K | Buy |
757
+5
| +0.7% | +$5.26K | 0.15% | 62 |
|
|
2024
Q1 | $724K | Sell |
752
-10
| -1% | -$9.63K | 0.24% | 44 |
|
|
2023
Q4 | $669K | Buy |
762
+4
| +0.5% | +$3.51K | 0.23% | 48 |
|
|
2023
Q3 | $624K | Buy |
758
+8
| +1% | +$6.58K | 0.25% | 47 |
|
|
2023
Q2 | $539K | Sell |
750
-5
| -0.7% | -$3.59K | 0.22% | 53 |
|
|
2023
Q1 | $620K | Buy |
755
+5
| +0.7% | +$4.11K | 0.32% | 45 |
|
|
2022
Q4 | $541K | Sell |
750
-7
| -0.9% | -$5.05K | 0.3% | 50 |
|
|
2022
Q3 | $521K | Buy |
757
+7
| +0.9% | +$4.82K | 0.33% | 51 |
|
|
2022
Q2 | $443K | Sell |
750
-20
| -3% | -$11.8K | 0.31% | 52 |
|
|
2022
Q1 | $538K | Buy |
770
+20
| +3% | +$14K | 0.29% | 55 |
|
|
2021
Q4 | $474K | Buy |
+750
| New | +$474K | 0.22% | 64 |
|